LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 21.17 | 770.25 | 1808 | 2008 | 0.9002 | 0.8536 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 21.17 | 770.25 | 2040 | 2008 | 1.0157 | 1.0227 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 23.39 | 770.25 | 2017 | 2244 | 0.8986 | 0.8662 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 23.39 | 770.25 | 2323 | 2244 | 1.0350 | 1.0451 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 25.62 | 770.25 | 2232 | 2514 | 0.8875 | 0.8650 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 25.62 | 770.25 | 2644 | 2514 | 1.0513 | 1.0595 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 27.84 | 770.25 | 2494 | 2833 | 0.8801 | 0.8686 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 27.84 | 770.25 | 2893 | 2833 | 1.0209 | 1.0221 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.06 | 770.25 | 2793 | 3106 | 0.8992 | 0.8971 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 30.06 | 770.25 | 3182 | 3106 | 1.0244 | 1.0241 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 32.28 | 770.25 | 3025 | 3392 | 0.8916 | 0.8955 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 32.28 | 770.25 | 3501 | 3392 | 1.0319 | 1.0295 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 34.50 | 770.25 | 3372 | 3712 | 0.9084 | 0.9171 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 34.50 | 770.25 | 3766 | 3712 | 1.0145 | 1.0128 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.73 | 770.25 | 3739 | 4086 | 0.9151 | 0.9276 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 36.73 | 770.25 | 4192 | 4086 | 1.0259 | 1.0214 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 38.95 | 770.25 | 4088 | 4543 | 0.8997 | 0.9191 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 38.95 | 770.25 | 4669 | 4543 | 1.0275 | 1.0213 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 41.17 | 770.25 | 4522 | 5010 | 0.9025 | 0.9255 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 41.17 | 770.25 | 5071 | 5010 | 1.0120 | 1.0089 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 43.39 | 770.25 | 5012 | 5404 | 0.9274 | 0.9471 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 43.39 | 770.25 | 5467 | 5404 | 1.0116 | 1.0082 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 45.61 | 770.25 | 5406 | 5813 | 0.9300 | 0.9508 | MN20160304_L02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 45.61 | 770.25 | 5976 | 5813 | 1.0280 | 1.0191 | MN20160304_L02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 47.83 | 770.25 | 5844 | 6223 | 0.9390 | 0.9587 | MN20160304_L02 | H11 |